To determine whether patients discharged after hospital admissions for conditions covered by national readmission programs who received care in emergency departments or observation units but were not readmitted within 30 days had an increased risk of death and to evaluate temporal trends in postdischarge acute care utilization in inpatient units, emergency departments, and observation units for these patients.
Introduction
The announcement and implementation of the US Hospital Readmissions Reduction Program (HRRP) were associated with a reduction in readmissions within 30 days of discharge for heart failure, acute myocardial infarction, and pneumonia, [1] [2] [3] [4] as shown by a decrease in the overall national rate of readmissions. Concerns existed that pressures to reduce readmissions had led to the evolution of care patterns that may have adverse consequences through reducing access to care in appropriate settings. [5] [6] [7] Therefore, determining whether patients who are seen in acute care settings, but not admitted to hospital, experience an increased risk of mortality is essential.
For numbered affiliations see end of the article. Correspondence to: R Khera rohankhera@outlook.com (or @rohan_khera on Twitter; ORCID 0000-0001-9467-6199) Additional material is published online only. To view please visit the journal online. doi: 10.1136/bmj.l6831 | BMJ 2020;368:l6831 | the bmj A question also arises about the association of the HRRP with the overall use of acute services in the 30 day post-discharge window. The reduction in readmissions could have occurred in the setting of changes that improved the recovery of patients and reduced the occurrence of clinical events needing acute care in the early post-discharge period. Alternatively, the decrease in readmissions might not have reduced the need for acute care but instead influenced clinicians to direct patients to the emergency department or observation units instead of pursuing hospital admission. The care of patients in the emergency department and observation units is appropriate only if they can be treated adequately in these settings without pursuing admission. An assessment of how outcomes of patients in these care settings have evolved is essential to mitigate concerns about the appropriateness of changes in patterns of acute care in the post-discharge period during the application of incentives to reduce readmission.
Accordingly, we determined whether the patients who sought acute care in the 30 days after discharge for heart failure, acute myocardial infarction, and pneumonia, the conditions the US Congress included in the HRRP, 3 8 9 but were not admitted to hospital, had an increased risk of mortality. In particular, we investigated whether people who had a post-discharge emergency department visit that did not lead to a hospital admission had an increase in mortality, to determine whether the incentive programs reduced access to the hospital and caused harm. We examined the characteristics of patients, and the change over time, by their type of acute care in the 30 days after admission to hospital.
We also evaluated the temporal trends in the utilization of post-discharge acute care, including readmissions, observation stays, and emergency department visits. We determined whether declines in readmissions were associated with increases in other types of acute care. We tested whether differences existed over time in the need for acute care in the 30 days after discharge. We also evaluated the period from day 31 through day 90 to determine whether a difference existed after the evaluation period of HRRP, to see whether any change in practice was limited to the period covered by the incentives.
Methods

Data source
We used the Medicare Standard Analytic Files that included 100% of inpatient and outpatient claims for the years 2008-16. The study period spanned the announcement and subsequent implementation of the HRRP in 2010 and 2012, respectively. 8 For each year, we included data for all fee-for-service Medicare beneficiaries aged 65 years and older who were admitted to hospital with a principal discharge diagnosis of heart failure, acute myocardial infarction, or pneumonia. The diagnoses were based on ICD (international classification of diseases) diagnosis codes that are included in the Centers for Medicare and Medicaid Services (CMS) measures for these conditions and are publicly available. [10] [11] [12] [13] Notably, the measure for pneumonia changed in 2014, but to ensure consistency we defined the study population for pneumonia across the study period by using the codes before the measure changed. 12 Furthermore, the coding scheme changed from ICD-9 to ICD-10 in October 2015. 14 Therefore, we used the CMS measure method that was rigorously tested for consistency in the patient population for each of three conditions across the transition. 10 To align the study cohort with the population of patients under the purview of the HRRP, we excluded those who were discharged against medical advice, died during hospital admission, or did not have at least 30 days' follow-up after discharge. The cohort was consistent with the specifications of the 30 day readmission metric of the CMS. 9 11-13 15 Post-discharge acute care utilization and mortality We used revenue center codes specific to claims submitted from observation stays and emergency department visits to identify these care settings. These included revenue center codes of 0762 and/or Healthcare Common Procedure Coding System code of G0378 for observation stays and revenue center codes of 0450, 0451, 0452, 0459, or 0981 for emergency department visits based on hospital outpatient claims data. These have been used in an outcome measure endorsed by the National Quality Forum and focused on post-discharge acute care. 16 We used the Medicare denominator files to identify patients who died from any cause and determined the temporal relation of their date of death to the day of discharge from hospital. 17 We defined 30 day post-discharge mortality as the proportion of patients discharged alive who died within 30 days of discharge.
Post-discharge care based patient groups
We examined post-discharge mortality in four mutually exclusive groups of patients defined on the basis of 
Readmission
Observation stay 
risk adjusted rates of outcomes
To account for changes in characteristics of patients, we constructed logistic regression models with utilization of care and mortality endpoints across care settings as dependent variables and covariates included in the risk adjustment models in the CMS measures for each condition as independent variables (supplementary tables A-C). We calculated the calendar year and monthly risk adjusted rates of utilization and mortality as the ratio of the observed rate during the period and the expected rate in the period, multiplied by the unadjusted rate over the study period. 9 To ensure consistency in covariates across ICD-9 and ICD-10 coding formats, as a part of the CMS measure design process, we mapped combinations of codes within each of the coding schemes to condition category codes for the covariates included in the model. The ICD-9 and ICD-10 codes included in the condition category codes, and data assessments showing consistency of condition category codes across the transition, are publicly available. 10 Changes have been made in the number of codes on inpatient claims over time. 18 19 We pursued additional analyses to evaluate whether differences in covariate selection strategies substantively altered the results. We first used inpatient and outpatient claims over the preceding 12 month period to assess covariates. We found that restricting the additional inpatient covariates available from the expansion of codes to the same number available previously did not substantively alter the risk adjustment models. 20 Nevertheless, to specifically determine how the strategy to identify covariates affects risk adjusted assessments in our analysis, we created a secondary cohort of hospital admissions with complete information on the order of inpatient claims (95% of the primary cohort) and used two covariate identification strategies, in which we combined outpatient claims over the preceding 12 months before the index hospital admission with either a fixed number of diagnoses from the claims across study period (nine secondary diagnosis codes, six procedure codes) or all inpatient codes (up to 25 diagnosis and procedure codes after expansion of inpatient code slots).
statistical analysis
First, we evaluated calendar year and monthly rates of post-discharge care within the 30 day postdischarge period as readmissions, observation stays, and emergency department visits between 2008 and 2016 for each of the three HRRP conditions. Next, for each of the three HRRP conditions, we evaluated the average annual change in rates of care utilization across different care settings, based on ordinary least squares regression of rates of post-discharge care use-rates of readmissions, observation stays, emergency department visits, or care in any of three acute care settings-against calendar years. We used the non-parametric runs test to evaluate and confirm the linearity of calendar year trends, which evaluates the randomness of distribution of data points around the regression line (see supplementary methods). 21 To better understand whether changes in patterns of care in a given post-acute care setting had progressed differently during the 30 days after discharge, we qualitatively evaluated care trends in these settings during post-discharge days 0-30 and 31-90 and We then evaluated calendar year and monthly trends in post-discharge 30 day mortality across the four patient groups, based on whether patients were readmitted, had an observation stay only, had an emergency department visit only, or had no care in any of these settings. We noted that these calendar year trends were linear over the course of the study period on the basis of visual assessment and using the runs test. We also confirmed normality of residuals and homoscedasticity of data, to ensure that assumptions of linear regression models were satisfied. We used an interaction term for post-discharge care group and calendar year in an analysis of covariance model to evaluate whether calendar year trends in mortality were significantly different across the patient groups. We evaluated average annual changes in mortality rates across care settings, reported as the coefficient of change of the respective outcome in an ordinary least square regression with calendar year as a continuous independent variable. To evaluate the contribution of changes in mortality across individual care settings to the overall changes in mortality in the 30 day postdischarge period, we calculated the proportion of annual change in overall mortality rates that occurred across the three settings.
Next, to specifically investigate the possible associations with the announcement and implementation of HRRP with changing utilization across care settings, we constructed interrupted time series models assessing how the slope of the temporal trends in monthly rates of post-discharge care in the three acute care settings changed with the announcement and implementation of the HRRP. These analyses are consistent with the approach outlined in previous studies. 19 22 To evaluate whether systematic differences in patients' characteristics were driving differences in outcomes, we evaluated differences in comorbidities and in-hospital events such as operative procedures and complications, as well as discharge disposition across these groups. We specifically evaluated whether comorbidities that are markers of debility, such as dementia, delirium, encephalopathy, pressure ulceration, and protein calorie malnutrition, varied across groups. The comorbidities were ascertained from all claims across inpatient and outpatient care settings in the year preceding the index hospital admission. The problems with the expansion of inpatient codes during this study period are mitigated with the use of comprehensive inpatient and outpatient codes. Finally, we assessed for markers for end of life care at discharge, including consultations for palliative care and discharge from hospital to hospice facilities.
We used SAS version 9.4 and Stata 14 for all analyses. The level of significance was set at 0.05. The study was reported in accordance with the STrengthening the Reporting of OBservational studies in Epidemiology (STROBE) recommendations, and its checklist is included in the online supplement.
Patient and public involvement
No patients were involved in the development of the research question or the outcome measures, or in developing plans for the design and implementation of the study.
results
During the study period, 3 772 924 hospital admissions for heart failure, 1 570 113 for acute 1) . We observed an increase in observation stays and emergency department visits during the 30 days after discharge across the three conditions, with an average annual increase in risk adjusted rates of observation stays of 0.13% (0.11% to 0.15%) for heart failure, 0.23% (0.19% to 0.26%) for acute myocardial infarction, and 0.11% (0.10% to 0.12%) for pneumonia among patients not readmitted (P<0.001 for all). Similarly, a smaller but significant increase occurred in rates of 30 day post-discharge emergency department visits for all three conditions, with an average annual increase of 0.04% (0.01% to 0.07%) for heart failure, 0.14% (0.09% to 0.19%) for acute myocardial infarction, and 0.06% (0.02% to 0.10%) for pneumonia (P<0.001 for all) (fig 1) . The combination of the increase in emergency department visits and observation stays was less than the decrease in readmissions for heart failure and pneumonia but not for acute myocardial infarction. Therefore, during this period, the overall acute care utilization in the 30 days after discharge decreased significantly for heart failure and pneumonia but not for acute myocardial infarction (fig 1) .
The increase in post-discharge observation stays and emergency department visits was also apparent during days 31-90 post-discharge ( fig 2) . We found no significant difference between the increase in risk adjusted rates of observation stays during postdischarge days 0-30 and 31-90, across calendar years for heart failure (P=0.62) or pneumonia (P=0.50). For acute myocardial infarction, post-discharge observation stays increased in both periods, but at a higher rate during days 0-30 than days 31-90 (P for differences in slopes=0.005). Similarly, emergency department visits increased during the first 30 days post-discharge as well as in the 31-90 day period, with a larger relative increase in the early post-discharge period for heart failure and acute myocardial infarction (P for differences in slopes=0.02 for heart failure and 0.003 for acute myocardial infarction), but not for pneumonia (P=0.13).
In interrupted time series models for both unadjusted and risk adjusted assessments, monthly rates of post-discharge readmission rates decreased substantially at HRRP announcement across the supplementary figures C-H; supplementary tables D-I) and continued to decrease at a slower rate after HRRP's implementation. The rates of observation stays were increasing before HRRP for all conditions. They accelerated after HRRP was announced, across both unadjusted and risk adjusted assessments for heart failure. For acute myocardial infarction and pneumonia, although unadjusted observation rates did not show an inflection, conservative risk adjustment assessments suggest an increase in observation stays that was approximately a quarter of the decrease in corresponding readmission rates (P for slope change<0.05) (supplementary tables H and I). Across all three conditions, we observed no inflection in rates of emergency department visits after HRRP announcement, but a significant increase occurred after HRRP implementation that was approximately a quarter of the decrease in readmissions during this period (P for slope change<0.05).
Mortality across post-discharge care groups
The overall post-discharge 30 day mortality was 8.7% for heart failure, 7.3% for acute myocardial infarction, and 8.4% for pneumonia. Post-discharge 30 day mortality was higher in patients with readmissions (13.2% for heart failure, 12.7% for acute myocardial infarction, and 15.3% for pneumonia) than in those with observation stays (4.5% for heart failure, 2.7% for acute myocardial infarction, and 4.6% for pneumonia), emergency department visits (9.7% for heart failure, 8.8% for acute myocardial infarction, and 7.8% for pneumonia), or no post-discharge acute care (7.2% for heart failure, 6.0% for acute myocardial infarction, and 6.9% for pneumonia).
Cumulatively, a third of post-discharge deaths occurred in people who were readmitted within the 30 day period (supplementary figure I). Among those not readmitted, most deaths within the 30 day postdischarge period occurred in people who had neither observation stays nor emergency department visits, which represented more than 60% of the overall postdischarge 30 day mortality across the conditions. Patients who were not readmitted but who received care in observation units or the emergency department represented less than 10% of all deaths in the postdischarge period (supplementary figure I) .
Over the study period, risk adjusted post-discharge mortality increased from 8.4% to 8.8% for heart failure and decreased from 7.5% to 7.0% for acute myocardial infarction and from 8.3% to 8.1% pneumonia (fig 4; unadjusted rates in supplementary figure J). The increase in post-discharge mortality for heart failure began before the announcement of the HRRP. The average risk adjusted post-discharge 30 day mortality increased by 0.05% (0.02% to 0.08%) per year for heart failure and decreased by 0.06% (−0.09% to −0.04%) per year for acute myocardial infarction during 2008-16 ( fig 5; unadjusted rates in supplementary figure K). Of the overall increase in mortality in patients with heart failure, increase in mortality was concentrated among people who were neither readmitted nor received care in an observation unit or an emergency department ( fig 5) . The rate of increase in mortality in this group without any acute care in inpatient units, observation wards, or the emergency department was 0.08% (0.05% to 0.12%) per year, rates of increase that exceeded the overall increase in post-discharge mortality in heart failure. In contrast, decrease in post-discharge mortality in patients with acute myocardial infarction was concentrated among those who were readmitted. For pneumonia, the overall mortality rates did not change over the study period. Therefore, increases in post-discharge mortality were limited to patients with heart failure who did not receive post-discharge acute care in of the three settings.
We observed no effects of the announcement or implementation or HRRP on temporal trends in mortality among patients who received post-discharge acute care in observation units or the emergency department. Specifically, in interrupted time series characteristics of patients by post-discharge care setting and outcomes We observed differences in markers of frailty and advanced healthcare needs between groups depending on whether they survived to post-discharge day 30 or died after seeking post-discharge care in various settings (table 1, table 2, table 3 ; supplementary tables P-R). Across all conditions, patients who died had a higher prevalence of markers of debility including dementia, functional disability, delirium, chronic skin ulceration, and protein calorie malnutrition. Among deceased patients, the prevalence rates of these conditions were substantially higher in those who died without having used any post-discharge acute care (table 1, table 2, table 3 ). Those who died also had a higher rate of markers of advanced disease such as cardiorespiratory failure, metastatic cancer, and acute leukemia; however, these markers did not differ between groups based on their post-discharge care use. Furthermore, the group of patients without post-discharge acute care use had much higher rates of palliative care consultations and discharge to hospice facilities. In the group of patients who died without using post-discharge acute care, 19.4% with heart failure, 21.0% with acute myocardial infarction, and 17.0% with pneumonia had a palliative care consultation before discharge. Notably, whereas 3.6% of patients with heart failure, 3.2% of patients with acute myocardial infarction, and 3.1% of patients with pneumonia were discharged to a hospice following the index hospital admission, among patients who died without using post-discharge acute care, 45.3% with heart failure, 49.1% with acute myocardial infarction, and 42.0% with pneumonia had been discharged to a hospice after the index hospital admission. We also saw disease specific temporal trends in discharges to hospice facilities. Across all patients, 3.6% with heart failure, 3.2% with acute myocardial infarction, and 3.2% with pneumonia were discharged to a hospice, with an increase in these discharges in heart failure and pneumonia but not in acute myocardial infarction (fig 7) .
discussion
Between 2008 and 2016, although the national readmission rate decreased significantly across all three conditions included in the HRRP (heart failure, acute myocardial infarction, and pneumonia), the use of emergency departments and observation units significantly increased. The decline in readmission rate was greater than the rise in the use of other acute care settings. Therefore, overall post-discharge acute care-representing the aggregate of readmissions, observation stays, and emergency department visits-decreased for patients with heart failure and pneumonia but not for patients with acute myocardial infarction. Patients receiving post-discharge care in the emergency department and observation units who were not readmitted had lower mortality than did those who were readmitted. Most deaths in the 30 days after discharge occurred in patients who did 1 We found that the rise in the care in these settings attenuated some of the reductions in readmissions during 2008-16, expanding on a similar observational analysis using Medicare data from 2012 to 2015. 23 Collectively, the patterns suggest a transition in how patients receive post-discharge acute care. The MedPAC, a non-partisan organization that does analyses for the US Congress, evaluated the HRRP and similarly found reductions in readmissions with increases in emergency department and observation visits. 24 Notably, we found an increase in these care settings that was not restricted to the 30 day reporting period and occurred at a similar rate during days 31-90 post-discharge. The MedPAC also found that observation stays and emergency department visits occurred among patients with conditions that were not targeted in the HRRP. 24 Therefore, we cannot be sure whether the changing patterns of post-discharge acute care was part of a strategy to reduce readmissions or whether they were related to other concurrent policy changes such as the wider implementation of criteria for inpatient hospital admissions that discouraged inclusion of short hospital stays. 3 25 26 Nevertheless, the overall rise in alternative post-discharge acute care in the 30 day period requires an assessment of whether patients' experience improved with this transition and whether avenues exist for further improvement of postdischarge care and recovery.
Outcomes in observation stays and emergency department visits
We found that patients who received care solely in observation units and emergency departments had lower rates of mortality than those who were admitted to hospital, indicating that these settings were likely utilized for patients at lower risk. Thus, the result does not support the concern that patients at high risk are denied access to the higher level services they need. 5 6 The changes in mortality-especially for patients with heart failure, who have experienced rising postdischarge mortality-largely occurred among people who had had no post-discharge acute care utilization. What remains unclear is whether these changes in post-discharge mortality, which were exclusively observed for patients with heart failure, represent a failure of appreciation that these patients needed acute care or a group with expected deaths in the setting of comfort centered, end of life care. We noted that this group of patients had high rates of palliative care utilization and discharge to hospice facilities. However, these observations do not completely explain the elevated mortality risk in patients who did not utilize post-discharge acute care. Moreover, although suggested in a previous study, 5 patients with pneumonia have not had a consistent rise in post-discharge mortality in our more contemporary assessment.
comparison with literature and implications for health policy
The study strongly suggests that the HRRP did not lead to harm through inappropriate triage of patients at high risk to observation units and the emergency department, and therefore provides evidence against calls to curtail the program owing to this theoretical concern. 6 The concern was mainly raised by one study that ascribed a rising mortality in the period spanning the announcement and implementation of HRRP to the effects of the program, also reporting that this increase was restricted to patients who were 5 This study, like others, 9 27-29 found that post-discharge mortality in these conditions was increasing nearly three years before the announcement of HRRP but ascribed an excess increase to HRRP after modeling HRRP's effects as changes across four 30 month periods discounting within period trends. 5 It also used inpatient data to define case mix and used a consistent number of codes after the expansion of coding slots on inpatient claims. The conclusions of the study contrasted with those of another that also found an increase in mortality from heart failure and pneumonia during 2006-14 but did not find inflections in the slopes of monthly rates of mortality in interrupted time series models, while specifically accounting for within period trends. 9 Moreover, it used inpatient, outpatient, and physician claims for risk adjustment, and used all claims data for identification of covariates after code slots expanded, without any analytic differences emerging owing to covariate selection strategies. Interestingly, a recent study by the authors whose initial study suggested a rise in mortality for heart failure and pneumonia in Medicare following implementation of HRRP found no changes in mortality for these conditions after modeling them as monthly changes during 2012-15, 23 despite including the same study population and the same data. The study also did not report mortality rates in observation units and emergency departments, despite a focus on the care in these settings. 23 Other studies using national Medicare data have focused on temporal trends in subgroups of hospitals and patients and are, therefore, not directly comparable to the above studies focusing on overall trends. 30 31 Finally, an analysis using 100 000 hospital admissions among Medicare beneficiaries in a quality improvement registry drawn from 500 US hospitals, which captured an inconceivably low two admissions for heart failure on average per hospital per month, did not replicate the secular trends in heart failure readmissions or mortality nationally. 22 32 It thus cannot form the basis of generalizable conclusions about the effects of the program. 32 The reassuring findings from our study complement hospital level assessments, which have found that reductions in readmissions are on average associated with reductions in mortality. 33 No evidence has been found to support the hypothesis of gaming of quality measures by delaying or deferring readmissions, as no discontinuities in readmission or mortality are seen around day 30. 34 Our study also explores other potential concurrent changes in patient care, such as end of life care, that may be reflected in post-discharge outcomes. However, whether markers of debility or end of life care need to be considered in measures cannot be directly inferred. Rates of these illnesses among patients who are readmitted are low, and, because they are potentially related to the quality of in-hospital care processes, excluding them in the assessment of readmission measures may not be appropriate. Finally, the current mortality measures were designed with considerations for such care needs before the index hospital admission, and patients receiving hospice care were excluded from the measure population. 35 36 These measures focus on post-admission 30 day mortality, which captures the entirety of the care experience of patients during the hospital admission and in the post-discharge period. Hospitals, therefore, focus on this composite of mortality. The current discussion about HRRP has exclusively focused on post-discharge mortality, despite a notable concurrent trend for reduction in in-hospital deaths, which have reduced at a rate comparable to the rise in post-discharge deaths. An independent assessment by MedPAC also found that risk adjusted cumulative in-hospital and postdischarge 30 day mortality have slightly decreased over the period spanning the introduction of the HRRP . 3 37 
limitations of study
Our study has some limitations. We were unable to identify patterns of acute care during the index hospital admission that would be associated with a higher rate of post-discharge acute care in observation units and emergency departments and whether these visits represented avenues for planned postdischarge follow-up care. Moreover, the proportion of these care encounters that were preventable remains poorly understood. Next, our assessment of discharge destination is exploratory and does not track the patient's location in the post-discharge period. Finally, we were unable to elucidate the cause of death among patients who did not seek post-acute care but died after a hospital admission owing to our use of deidentified data. However, this is unlikely to represent refusal of care, as there are specific laws against refusal of care to acutely ill patients requesting emergency care. Moreover, current quality measures do not disincentivize care in the emergency department or observation units, and no incentives exist for hospitals to refuse acute or emergent care. Also, our study focuses on all US hospitals and not merely the hospital with the index admission, and the other hospitals do not have a reason to refuse needed care. An investigation into these deaths remains important.
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